Skip to main content
SpringerLink
Log in

The Role of Photodynamic Therapy and Cryotherapy for the Management of Barrett’s Esophagus

  • Chapter
  • First Online:
The SAGES Manual of Foregut Surgery

Abstract

Gastroesophageal reflux can cause injury to the normal stratified squamous epithelium of the esophagus. This injury may lead to replacement of the normal esophageal lining by a metaplastic columnar intestinal-like epithelium known as Barrett’s esophagus (BE). The clinical relevance of BE lies in its sequential progression from intestinal metaplasia (IM) to low-grade dysplasia (LGD), high-grade dysplasia (HGD), and, finally, invasive adenocarcinoma. In the absence of dysplasia, BE is associated with a low annual incidence of progression to adenocarcinoma (less than 0.5), but the incidence of progression to adenocarcinoma is up to five times as high when dysplasia is present. The management of BE with dysplasia and early cancer has shifted over the years, moving away from surgical resection (esophagectomy) to diagnostic and therapeutic endoscopy. Endoscopic therapy aims to remove the metaplastic or dysplastic tissue to a depth that destroys all the BE but minimizes damage to the submucosal layer of the esophagus to avoid stricture formation and transmural injury. Several treatment options—endoscopic mucosal resection (EMR) and tissue ablative therapies such as radiofrequency ablation (RFA), photodynamic therapy (PDT), and cryotherapy (CT)—have been recognized as safe and effective therapies to accomplish this and are now the standard of care in many expert centers. This chapter will focus on the role of photodynamic therapy and cryotherapy in the management of BE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pellegrini CA, Pohl D. High-grade dysplasia in Barrett’s esophagus: surveillance or operation? J Gastrointest Surg. 2000;4(2):131–4.

    Article  CAS  Google Scholar 

  2. Hvid-Jensen F, et al. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.

    Article  CAS  Google Scholar 

  3. Rastogi A, et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67(3):394–8.

    Article  Google Scholar 

  4. Sharma P, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4(5):566–72.

    Article  Google Scholar 

  5. Desai TK, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61(7):970–6.

    Article  Google Scholar 

  6. Shakhatreh MH, et al. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett’s esophagus. Am J Gastroenterol. 2014;109(12):1862–8. quiz 1861, 1869.

    Article  Google Scholar 

  7. Dunkin BL, Lyons C. Endoscopic therapies for Barrett’s esophagus. In: Swanstrom LL, Soper NJ, editors. Mastery of endoscopic and laparoscopic surgery. Philadelphia: Lippincott Williams & Wilkins; 2014.

    Google Scholar 

  8. Sappati Biyyani RS, Chak A. Barrett’s esophagus: review of diagnosis and treatment. Gastroenterol Rep (Oxf). 2013;1(1):9–18.

    Article  Google Scholar 

  9. Overholt BF, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc. 2007;66(3):460–8.

    Article  Google Scholar 

  10. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49(1):1–7.

    Article  CAS  Google Scholar 

  11. Overholt BF, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62(4):488–98.

    Article  Google Scholar 

  12. Wang KK, Kim JY. Photodynamic therapy in Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2003;13(3):483–9. vii

    Article  Google Scholar 

  13. Wolfsen HC, et al. Clinical experience of patients undergoing photodynamic therapy for Barrett’s dysplasia or cancer. Aliment Pharmacol Ther. 2004;20(10):1125–31.

    Article  CAS  Google Scholar 

  14. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc. 2002;77(11):1176–81.

    Article  CAS  Google Scholar 

  15. Gossner L, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;114(3):448–55.

    Article  CAS  Google Scholar 

  16. Ackroyd R, et al. Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut. 2000;47(5):612–7.

    Article  CAS  Google Scholar 

  17. Pech O, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc. 2005;62(1):24–30.

    Article  Google Scholar 

  18. Barr H, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348(9027):584–5.

    Article  CAS  Google Scholar 

  19. Ackroyd R, et al. 5-Aminolevulinic acid photosensitization of dysplastic Barrett’s esophagus: a pharmacokinetic study. Photochem Photobiol. 1999;70(4):656–62.

    CAS  PubMed  Google Scholar 

  20. Dunn JM, et al. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus. Lasers Med Sci. 2013;28(3):707–15.

    Article  CAS  Google Scholar 

  21. Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2011;106(11):1899–908. quiz 1909.

    Article  Google Scholar 

  22. Van Laethem JL, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut. 2000;46(4):574–7.

    Article  Google Scholar 

  23. Ertan A, et al. Photodynamic therapy vs radiofrequency ablation for Barrett’s dysplasia: efficacy, safety and cost-comparison. World J Gastroenterol. 2013;19(41):7106–13.

    Article  CAS  Google Scholar 

  24. Azarm A, et al. Endoscopic management of Barrett’s esophagus: advances in endoscopic techniques. Dig Dis Sci. 2012;57(12):3055–64.

    Article  Google Scholar 

  25. Greenwald BD, Dumot JA. Cryotherapy for Barrett’s esophagus and esophageal cancer. Curr Opin Gastroenterol. 2011;27(4):363–7.

    Article  Google Scholar 

  26. Johnston MH, et al. Cryoablation of Barrett’s esophagus: a pilot study. Gastrointest Endosc. 2005;62(6):842–8.

    Article  Google Scholar 

  27. Greenwald BD, et al. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus. 2010;23(1):13–9.

    Article  Google Scholar 

  28. Shaheen NJ, et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc. 2010;71(4):680–5.

    Article  Google Scholar 

  29. Gosain S, et al. Liquid nitrogen spray cryotherapy in Barrett’s esophagus with high-grade dysplasia: long-term results. Gastrointest Endosc. 2013;78(2):260–5.

    Article  Google Scholar 

  30. Canto MI. Carbon dioxide (CO2) cryotherapy is a safe and effective treatment of Barrett’s esophagus (BE) with HGD/Intramucosal carcinoma. Gastrointest Endosc. 2009;69(5):AB341–AB341.

    Article  Google Scholar 

  31. Xue HB, et al. A pilot study of endoscopic spray cryotherapy by pressurized carbon dioxide gas for Barrett’s esophagus. Endoscopy. 2011;43(5):379–85.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Maryland School of Medicine, Baltimore, MD, USA

    Hope T. Jackson

  2. University of Washington Medical School, Seattle, WA, USA

    Andrew S. Wright

Authors
  1. Hope T. Jackson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew S. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew S. Wright .

Editor information

Editors and Affiliations

  1. University of Alabama at Birmingham , Birmingham, AL, USA

    Jayleen Grams

  2. The Ohio State University, Columbus, OH, USA

    Kyle A. Perry

  3. Brigham and Women’s Hospital, Boston, MA, USA

    Ali Tavakkoli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 SAGES

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jackson, H.T., Wright, A.S. (2019). The Role of Photodynamic Therapy and Cryotherapy for the Management of Barrett’s Esophagus. In: Grams, J., Perry, K., Tavakkoli, A. (eds) The SAGES Manual of Foregut Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-96122-4_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96122-4_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96121-7

  • Online ISBN: 978-3-319-96122-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation